AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ANTX…

AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

AN2 Therapeutics, Inc.

ANTX · CIK 1880438

4 · Aug 19, 2026 · Director Readnour Robin Shane sold 35.40K shares at $6.01/share ($212.7K)

4

Director Readnour Robin Shane sold 35.40K shares at $6.01/share ($212.7K)

Filed: Aug 19, 2026
Period: Aug 17, 2026
Accession: 0001193125-26-357225
Filer: AN2 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov